{"id":"https://openalex.org/W2106400925","doi":"https://doi.org/10.2174/1381612053764797","title":"Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders","display_name":"Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders","alternate_titles":[],"publication_year":2005,"publication_date":"2005-04-29","ids":{"openalex":"https://openalex.org/W2106400925","doi":"https://doi.org/10.2174/1381612053764797","mag":"2106400925","pmid":"https://pubmed.ncbi.nlm.nih.gov/15892661"},"language":"en","primary_location":{"id":"doi:10.2174/1381612053764797","doi":"https://doi.org/10.2174/1381612053764797","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612053764797","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2106400925"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001950169","display_name":"Guy Griebel","orcid":"https://orcid.org/0000-0002-6052-9438","observed_orcids":["https://orcid.org/0000-0002-6052-9438"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Guy Griebel","raw_affiliation_strings":["CNS Research Department, Sanofi-Aventis, 31 Avenue Paul Vaillant Couturier, Bagneux, 92220, France. guy.griebel@sanofi-aventis.com","CNS Research Department, Sanofi-Aventis, 31 Avenue Paul Vaillant Couturier, Bagneux, 92220, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNS Research Department, Sanofi-Aventis, 31 Avenue Paul Vaillant Couturier, Bagneux, 92220, France. guy.griebel@sanofi-aventis.com","institution_ids":["https://openalex.org/I3018075036"]},{"raw_affiliation_string":"CNS Research Department, Sanofi-Aventis, 31 Avenue Paul Vaillant Couturier, Bagneux, 92220, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017608017","display_name":"Jeanne Stemmelin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeanne Stemmelin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109572313","display_name":"Claudine Serradeil\u2010Le Gal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudine Gal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110129721","display_name":"Philippe Soubri\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Philippe Soubrie","raw_affiliation_strings":["CNS Research Department, Sanofi-Aventis, 31 Avenue Paul Vaillant Couturier, Bagneux, 92220, France.,France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNS Research Department, Sanofi-Aventis, 31 Avenue Paul Vaillant Couturier, Bagneux, 92220, France.,France","institution_ids":["https://openalex.org/I3018075036"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110129721"],"corresponding_institution_ids":["https://openalex.org/I3018075036"],"apc_list":null,"apc_paid":null,"fwci":3.0958,"has_fulltext":false,"cited_by_count":90,"citation_normalized_percentile":{"value":0.9202681,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"11","issue":"12","first_page":"1549","last_page":"1559"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.2094999998807907,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11541","display_name":"Neuroendocrine regulation and behavior","score":0.1738000065088272,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/stress-related-disorders","display_name":"stress-related disorders","score":0.7889999747276306},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.7649999856948853},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9829999804496765},{"id":"https://openalex.org/keywords/hypothalamic-pituitary-adrenal-axis","display_name":"hypothalamic-pituitary-adrenal axis","score":0.968999981880188},{"id":"https://openalex.org/keywords/corticotropin-releasing-factor","display_name":"corticotropin-releasing factor","score":0.9240000247955322},{"id":"https://openalex.org/keywords/acth-release","display_name":"ACTH release","score":0.9129999876022339},{"id":"https://openalex.org/keywords/noradrenaline-release","display_name":"noradrenaline release","score":0.9860000014305115},{"id":"https://openalex.org/keywords/hyperthermia","display_name":"hyperthermia","score":0.7570000290870667},{"id":"https://openalex.org/keywords/antidepressant-like-effects","display_name":"antidepressant-like effects","score":0.8650000095367432},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.7850000262260437},{"id":"https://openalex.org/keywords/aggression","display_name":"aggression","score":0.7739999890327454},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.6980000138282776},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.7713850140571594},{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.6086769700050354},{"id":"https://openalex.org/C2776370428","wikidata":"https://www.wikidata.org/wiki/Q21124841","display_name":"Vasopressin","level":2,"score":0.5986875295639038},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.555300772190094},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5411106944084167},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5179014205932617},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5114654302597046},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.502467155456543},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.48482978343963623},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.45141980051994324},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.44269368052482605},{"id":"https://openalex.org/C205044023","wikidata":"https://www.wikidata.org/wiki/Q4778117","display_name":"Anxiogenic","level":4,"score":0.4298960566520691},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.35893285274505615},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1264575719833374}],"mesh":[{"descriptor_ui":"D000374","descriptor_name":"Aggression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017483","descriptor_name":"Receptors, Vasopressin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065092","descriptor_name":"Antidiuretic Hormone Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/1381612053764797","doi":"https://doi.org/10.2174/1381612053764797","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612053764797","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:15892661","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15892661","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":80,"referenced_works":["https://openalex.org/W95534438","https://openalex.org/W1486425129","https://openalex.org/W1508884585","https://openalex.org/W1560019823","https://openalex.org/W1623788409","https://openalex.org/W1907295447","https://openalex.org/W1948173875","https://openalex.org/W1967950137","https://openalex.org/W1968660884","https://openalex.org/W1968772088","https://openalex.org/W1970083794","https://openalex.org/W1977665929","https://openalex.org/W1980055778","https://openalex.org/W1984093704","https://openalex.org/W1986878594","https://openalex.org/W1988230174","https://openalex.org/W1989992663","https://openalex.org/W2000592789","https://openalex.org/W2003547326","https://openalex.org/W2004144457","https://openalex.org/W2007060613","https://openalex.org/W2012986211","https://openalex.org/W2018303025","https://openalex.org/W2021240950","https://openalex.org/W2022290338","https://openalex.org/W2023514678","https://openalex.org/W2031254814","https://openalex.org/W2037692685","https://openalex.org/W2038284802","https://openalex.org/W2039413967","https://openalex.org/W2041036432","https://openalex.org/W2043337264","https://openalex.org/W2044340614","https://openalex.org/W2046364593","https://openalex.org/W2047638952","https://openalex.org/W2048146758","https://openalex.org/W2049210516","https://openalex.org/W2053048310","https://openalex.org/W2054516409","https://openalex.org/W2056249673","https://openalex.org/W2058523218","https://openalex.org/W2058806365","https://openalex.org/W2061489766","https://openalex.org/W2061945417","https://openalex.org/W2062200533","https://openalex.org/W2065986755","https://openalex.org/W2068709061","https://openalex.org/W2069660825","https://openalex.org/W2070663077","https://openalex.org/W2075609074","https://openalex.org/W2079703471","https://openalex.org/W2085176718","https://openalex.org/W2089299823","https://openalex.org/W2089538279","https://openalex.org/W2090364796","https://openalex.org/W2096700862","https://openalex.org/W2098391261","https://openalex.org/W2099323802","https://openalex.org/W2101653844","https://openalex.org/W2104748479","https://openalex.org/W2119147856","https://openalex.org/W2125716823","https://openalex.org/W2126191582","https://openalex.org/W2129340317","https://openalex.org/W2135935889","https://openalex.org/W2142802556","https://openalex.org/W2144676312","https://openalex.org/W2158888787","https://openalex.org/W2162632863","https://openalex.org/W2170155163","https://openalex.org/W2178144275","https://openalex.org/W2293895349","https://openalex.org/W2313517384","https://openalex.org/W2316600543","https://openalex.org/W2320031091","https://openalex.org/W2397426560","https://openalex.org/W2430741025","https://openalex.org/W2462181182","https://openalex.org/W2586587501","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W1594629709","https://openalex.org/W1986878594","https://openalex.org/W2023907117","https://openalex.org/W2003547326","https://openalex.org/W2070279391","https://openalex.org/W2093651141","https://openalex.org/W1985693247","https://openalex.org/W1995081746","https://openalex.org/W2782497620","https://openalex.org/W2901139531"],"abstract_inverted_index":{"Since":[0],"vasopressin":[1,65],"has":[2,27],"been":[3,28],"shown":[4],"to":[5,19,100,119,193,214,232],"be":[6],"critical":[7],"for":[8,38,60,186,236],"adaptation":[9],"of":[10,24,41,46,64,69,114,121,135,199,239,244],"the":[11,21,47,62,96,111,115,124,237],"hypothalamo-pituitary-adrenal":[12],"axis":[13],"during":[14],"stress":[15,93],"through":[16],"its":[17,215],"ability":[18],"potentiate":[20],"stimulatory":[22],"effect":[23],"CRF,":[25],"it":[26,209],"hypothesized":[29],"that":[30,120,134,171,181,195,224],"this":[31],"peptide":[32],"may":[33],"provide":[34],"a":[35,57,229],"good":[36],"opportunity":[37],"pharmacological":[39],"treatment":[40,238],"stress-related":[42,106],"disorders.":[43,246],"The":[44],"availability":[45],"first":[48],"orally":[49],"active":[50],"non-peptide":[51],"V(1b)":[52,172,225],"receptor":[53,173,226],"antagonist,":[54],"SSR149415,":[55],"opened":[56],"new":[58],"era":[59],"examining":[61],"role":[63],"in":[66,108,128,151,161],"animal":[67],"models":[68],"anxiety":[70,129,153,245],"and":[71,86,146,208,241],"depression.":[72],"In":[73],"rats,":[74],"SSR149415":[75,156,182,196],"blocked":[76],"several":[77],"endocrine":[78],"(i.e.":[79,83,88],"ACTH":[80],"release),":[81],"neurochemical":[82],"noradrenaline":[84],"release)":[85],"autonomic":[87],"hyperthermia)":[89],"responses":[90],"following":[91],"various":[92],"exposures.":[94],"Moreover,":[95],"drug":[97],"was":[98,117,131],"able":[99],"attenuate":[101],"some":[102,242],"but":[103],"not":[104,211],"all":[105],"behaviors":[107],"rodents.":[109],"While":[110],"antidepressant-like":[112,218],"activity":[113],"compound":[116],"comparable":[118],"reference":[122],"antidepressants,":[123],"overall":[125],"profile":[126],"displayed":[127],"tests":[130],"different":[132],"from":[133],"classical":[136],"anxiolytics,":[137],"such":[138],"as":[139],"benzodiazepines.":[140],"These":[141],"latter":[142],"were":[143],"highly":[144],"effective":[145],"reliably":[147],"produced":[148],"robust":[149],"effects":[150,159,201],"most":[152],"tests,":[154],"while":[155],"showed":[157],"clear-cut":[158],"only":[160],"particularly":[162],"stressful":[163],"situations.":[164],"Experiments":[165],"with":[166,177],"mice":[167],"or":[168,205,217],"hamsters":[169],"indicated":[170],"blockade":[174],"is":[175,191,197],"associated":[176],"reduced":[178],"aggressiveness,":[179],"suggesting":[180],"could":[183],"prove":[184],"useful":[185],"treating":[187],"aggressive":[188],"behavior.":[189],"It":[190],"important":[192],"note":[194],"devoid":[198],"adverse":[200],"on":[202],"motor":[203],"functions":[204],"cognitive":[206],"processes,":[207],"did":[210],"produce":[212],"tolerance":[213],"anxiolytic-":[216],"activity.":[219],"Altogether,":[220],"these":[221],"findings":[222],"suggest":[223],"antagonists":[227],"represent":[228],"promising":[230],"alternative":[231],"agents":[233],"currently":[234],"used":[235],"depression":[240],"forms":[243]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2106400925","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
